028sek
1,6 %
Date:2026-04-02Time:13:30:00Latest report:Q4-2025List:First NorthTicker:ACARIX
Market Cap:324 msekEnterprise Value:306 msekNet Sales:7,36 msekEarnings:-48,1 msekEmployees:0ISIN:SE0009268717

Ratios

10-year key figure history for Acarix turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Acarix with index and moving average MA50 and MA200.

Stockprice:0,28
MA50:0,28
MA200:0,31
Price/MA200:-8,9 %
RSI (14):50,9
Price/MA50:0,4 %

Description

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Medical Equipment